全文获取类型
收费全文 | 140197篇 |
免费 | 13945篇 |
国内免费 | 7099篇 |
专业分类
耳鼻咽喉 | 1178篇 |
儿科学 | 2153篇 |
妇产科学 | 1993篇 |
基础医学 | 32939篇 |
口腔科学 | 3724篇 |
临床医学 | 11353篇 |
内科学 | 19882篇 |
皮肤病学 | 2385篇 |
神经病学 | 9472篇 |
特种医学 | 2927篇 |
外国民族医学 | 27篇 |
外科学 | 12232篇 |
综合类 | 19598篇 |
现状与发展 | 32篇 |
一般理论 | 4篇 |
预防医学 | 4666篇 |
眼科学 | 3286篇 |
药学 | 12591篇 |
29篇 | |
中国医学 | 3945篇 |
肿瘤学 | 16825篇 |
出版年
2024年 | 173篇 |
2023年 | 1835篇 |
2022年 | 3219篇 |
2021年 | 4851篇 |
2020年 | 4525篇 |
2019年 | 4671篇 |
2018年 | 4858篇 |
2017年 | 5050篇 |
2016年 | 5225篇 |
2015年 | 5828篇 |
2014年 | 9489篇 |
2013年 | 11048篇 |
2012年 | 8413篇 |
2011年 | 9778篇 |
2010年 | 7837篇 |
2009年 | 7598篇 |
2008年 | 7995篇 |
2007年 | 7839篇 |
2006年 | 7039篇 |
2005年 | 6011篇 |
2004年 | 5083篇 |
2003年 | 4132篇 |
2002年 | 3058篇 |
2001年 | 2635篇 |
2000年 | 2240篇 |
1999年 | 1908篇 |
1998年 | 1747篇 |
1997年 | 1618篇 |
1996年 | 1484篇 |
1995年 | 1486篇 |
1994年 | 1355篇 |
1993年 | 1149篇 |
1992年 | 923篇 |
1991年 | 868篇 |
1990年 | 749篇 |
1989年 | 747篇 |
1988年 | 626篇 |
1987年 | 572篇 |
1986年 | 496篇 |
1985年 | 808篇 |
1984年 | 749篇 |
1983年 | 528篇 |
1982年 | 684篇 |
1981年 | 516篇 |
1980年 | 459篇 |
1979年 | 385篇 |
1978年 | 259篇 |
1977年 | 194篇 |
1976年 | 190篇 |
1975年 | 81篇 |
排序方式: 共有10000条查询结果,搜索用时 500 毫秒
1.
《Cancer radiothérapie》2022,26(4):611-615
In order to provide more convenient irradiation regimens for patient comfort, radiation facility organization and health expenses, new hypofractionated protocols have been evaluated. Moderately (dose/fraction: 2.3 to 3 Gy), then ultra (dose/fraction: 5.2 to 6.1 Gy) hypofractionated irradiations were first validated. The current question is: is it possible to go forward using extreme hypofractionated regimens (EHR) based on 1 to 3 fractions. Different irradiation techniques are under investigation. However, brachytherapy remains the smartest way to deliver a high dose in a small volume. We report prospective and retrospective study results which evaluated EHR for breast and prostate brachytherapy. While oncological outcome and toxicity profile appear extremely encouraging for low-risk breast cancer after a 1 to 4 fractions (6.25 to 20 Gy/fraction), the use of a single fraction of 19 to 23 Gy appears debatable for prostate cancer. Brachytherapy represents an emblematic example of EHR but longer follow-up and more mature results are awaited in order to specify the right indications and refine the EQD2 calculation method including new biological and technical factors. 相似文献
2.
目的 对比研究朝鲜淫羊藿酸性多糖酯化还原前后的理化特性,并探讨其改善油酸诱导的肝癌HepG2细胞脂质堆积活性的差异。方法 采用高效凝胶渗透色谱法测定朝鲜淫羊藿酸性多糖(EFPA)的均一性和分子量,高效液相色谱法测定EFPA和酯化还原后朝鲜淫羊藿酸性多糖(EFPA-R)的单糖组成;采用油酸(OA)处理HepG2细胞诱导建立脂质蓄积模型,不同浓度EFPA与EFPA-R(10、30、100、300 μg·mL-1)分别和OA共同作用于细胞24 h,采用CCK-8试剂盒测定细胞存活率,油红O染色观察细胞内脂滴蓄积情况,并采用试剂盒测定细胞内总胆固醇(TC)、甘油三酯(TG)含量。结果 EFPA为成分均一的多糖组分,分子量为125.8 kDa,由甘露糖、葡萄糖、半乳糖、葡萄糖醛酸和阿拉伯糖组成,摩尔比为1.7∶7.4∶1.4∶1.8∶1.0,葡萄糖占比最大,EFPA-R由甘露糖、葡萄糖、半乳糖和阿拉伯糖组成,摩尔比为0.8∶10.6∶2.1∶1.0;在10-300 μg·mL-1范围内,EFPA和EFPA-R对HepG2细胞的抑制作用较弱,作为给药浓度;与空白组相比,模型组细胞中TC、TG含量显著升高(P < 0.01),细胞内红色脂滴显著增多,与模型组相比,EFPA可显著降低细胞中TC、TG含量(P < 0.01),明显减少细胞内红色脂滴(P < 0.05或P < 0.01),EFPA-R干预后细胞则无明显变化。结论 EFPA可明显改善HepG2细胞脂质堆积情况,且呈现剂量依赖性,而半乳糖醛酸(GalA)的存在可能是其抑制HepG2细胞脂质蓄积的关键因素。 相似文献
3.
4.
5.
《Cancer cell》2022,40(2):153-167.e11
- Download : Download high-res image (229KB)
- Download : Download full-size image
6.
7.
8.
9.
Bortezomib is a novel proteasome inhibitor, which has been successfully used to treat mantle cell lymphoma and multiple myeloma. However, the direct effects of bortezomib on acute promyelocytic leukaemia (APL) have not been fully investigated. In the present study, the WST-8 assay, western blotting, flow cytometry, monodansylcadaverine staining and transmission electron microscopy were performed. It was demonstrated that bortezomib treatment induced a time- and dose-dependent decrease in the viability of NB4 cells. Bortezomib treatment induced cell apoptosis in NB4 cells, as assessed by Annexin V/propidium iodide analysis, and the detection of cleaved caspase-3, cleaved poly(ADP-ribose) polymerase, Bax and Bcl-2 expression. Furthermore, bortezomib treatment induced autophagy in NB4 cells, as indicated by autophagosome formation, p62 degradation, LC3-I to LC3-II conversion and formation of acidic autophagic vacuoles. Notably, autophagy induced by bortezomib was initiated prior to apoptosis. Inhibition of autophagy by knocking down Beclin-1 expression increased bortezomib-induced apoptosis in NB4 cells. Therefore, the present study revealed that the combination of bortezomib and autophagy inhibition may be a potential treatment strategy for APL. 相似文献
10.
《Transfusion and apheresis science》2022,61(4):103488
The COVID-19 pandemic caused by the SARS-CoV-2 virus has significantly disrupted and burdened the diagnostic workup and delivery of care, including transfusion, to cancer patients across the globe. Furthermore, cancer patients suffering from solid tumors or hematologic malignancies were more prone to the infection and had higher morbidity and mortality than the rest of the population. Major signaling pathways have been identified at the intersection of SARS-CoV-2 and cancer cells, often leading to tumor progression or alteration of the tumor response to therapy. The reactivation of oncogenic viruses has also been alluded to in the context and following COVID-19. Paradoxically, certain tumors responded better following the profound infection-induced immune modulation. Unveiling the mechanisms of the virus-tumor cell interactions will lead to a better understanding of the pathophysiology of both cancer progression and virus propagation. It would be challenging to monitor, through the different cancer registries, retrospectively, the response of patients who have been previously exposed to the virus in contrast to those who have not contracted the infection. 相似文献